Health
Targeted therapies could exploit unique metabolic features of pancreatic cancer cells – News-Medical.Net
Probing the unique biology of human pancreatic cancer cells in a laboratory has yielded unexpected insights of a weakness that can be used against the cells to…
Probing the unique biology of human pancreatic cancer cells in a laboratory has yielded unexpected insights of a weakness that can be used against the cells to kill them.
Led by Princess Margaret Cancer Centre (PM) Scientist Dr. Marianne Koritzinsky, researchers showed that about half of patient-derived pancreatic cancer cell lines are highly dependent or “addicted” to the protein peroxiredoxin 4 (PRDX4), as a result of the altered metabolic state of the cancer cell.
This addiction is vital for…
-
Business16 hours agoWarning! These ASX 200 shares were just downgraded
-
Business14 hours ago2 monthly payers you’ll want to own in 2025 and beyond
-
Noosa News9 hours agoVegetables and herbs you can easily and cheaply grow from seeds
-
Business10 hours agoMacquarie predicts more than 10% upside for this ASX small-cap mining stock